VIATRIS INC (VTRS)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for VTRS
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| VTRS | Chief Executive Officer; Chair of the Science and Technology Committee | 60 | ["CEO and Public Company Management", "Finance", "Accounting", "Capital Markets", "Global Business", "Strategy and M&A Experience", "Human Capital Management", "Healthcare Industry Experience"] | ["Audit", "Science and Technology", "Chair", "Audit Committee", "Science and Technology Committee"] | 2026 |
Companies shown below are based on exact name match for the selected Director
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| AVTR | Chief Executive Officer, Tessera Therapeutics | 60 | ["Chief Executive Officer of Tessera Therapeutics, Inc.", "Vice Chairman and President at AbbVie Inc.", "Executive Vice President, Research & Development at AbbVie Inc.", "Chief Scientific Officer at AbbVie Inc.", "Senior Vice President, Global Development at Amgen, Inc.", "Chief Medical Officer at Amgen, Inc.", "M.D. from Johns Hopkins University", "Residency and Fellowship Training at Massachusetts General Hospital and Harvard Medical School", "Bachelor\u2019s Degree in Biochemistry from the University of Maryland"] | ["Compensation & Human Resources (Chair)", "Science & Technology", "Compensation & Human Resources"] | 2026 |
Biography sourced from the proxy statement filing.
Chief Executive Officer (since 2022), Tessera Therapeutics, Inc. (Tessera), a private biotechnology company focused on genome engineering CEO-Partner (since 2022), Flagship Pioneering, Inc. a life sciences venture capital company Held management roles of increasing responsibility (2014 - 2022) including Vice Chairman and President, (2018 - 2022), AbbVie Inc. (NYSE: ABBV), a pharmaceutical company Held management roles of increasing responsibility (2004 - 2014) including Senior Vice President, Global Development, and Chief Medical Officer (2012 - 2014), Amgen Inc. (Nasdaq: AMGN), a pharmaceutical company Key Skills and Experience: CEO and Public Company Management, Finance, Accounting, and Capital Markets, Global Business, and Strategy and M&A Experience developed during his various executive roles where he oversaw research and clinical development projects, financial reporting and capital markets activity, along with leading business development initiatives, along with all other aspects of company management Human Capital Management gained as the Chief Executive Officer of Tessera Dr. Severino also brings Healthcare Industry Experience to the Board Other Current Public Company Boards: Avantor, Inc. (NYSE: AVTR) (since 2020), Director and Chair of the Compensation and Human Resources Committee and member of the Science and Technology Committee Other Current Private Company Boards: Tessera (since 2022), Director Montai Therapeutics, Inc. (since 2023), Director Quotient Therapeutics, Inc. (since 2023), Director Other Organizations: Former Trustee, The Field Museum of Natural History